Article

Bausch & Lomb PureVision contact lenses available

Bausch & Lomb's PureVision contact lenses are available in the United States once again, following the recent successful resolution of a patent dispute.

May 1

- Fort Lauderdale, FL - Bausch & Lomb's PureVision contact lenses are available in the United States once again, following the recent successful resolution of a patent dispute.

The silicone hydrogel lenses can be prescribed for daily wear or continuous wear for up to 30 days and nights, according to Paul G. Howes, president of Bausch & Lomb North America. "The PureVision lens design provides wearers exceptional vision, health, and comfort, whether the lenses are removed each day or worn 30 days straight, including overnight," Howes said.

Ophthalmologists and optometrists across the United States soon will receive the lens sets, containing a range of PureVision lens prescription powers, to help fit their patients. More information is available at www.purevision.com.

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.